Product Program year 2025 Source: CMS Open Payments

Revolve

Device Plastic Surgery

Open in the dashboard

General payments

$3,928,558

7,960 payments

Research payments

$9,308

1 payment

Through program year 2025, $3,928,558 in general payments and $9,308 in research payments were reported against Revolve (Plastic Surgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $784,044 1,448
2024 General $1,107,399 2,468
2023 General $409,357 1,205
2022 General $537,693 565
2021 General $933,412 1,945
2020 General $156,654 329
2020 Research $9,308 1

Breakdown

Who paid General payments · program years 2020–2025
  1. AbbVie, Inc. $2,300,800 5,121 payments
  2. Allergan Inc. $1,627,759 2,839 payments
Top recipients General payments · program year 2025
  1. Michael Edwards Plastic Surgery · Las Vegas, NV $40,371 5% · 35 payments
  2. Gaurav Bharti Plastic Surgery · Johnson City, TN $33,604 4% · 26 payments
  3. Nicholas Clavin Plastic Surgery · Charlotte, NC $33,167 4% · 29 payments
  4. Theodore Nyame Plastic Surgery · Charlotte, NC $31,983 4% · 26 payments
  5. Caroline Glicksman Plastic Surgery · Sea Girt, NJ $28,306 4% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Plastic Surgery $525,683 75% · 121 practitioners
  2. Plastic and Reconstructive Surgery Surgery $134,260 19% · 58 practitioners
  3. Optometrist $17,352 2% · 1 practitioner
  4. Surgery $16,523 2% · 11 practitioners
  5. Dermatology $5,706 <1% · 3 practitioners

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. North Carolina $111,369 14% · 8 recipients
  2. California $83,181 11% · 36 recipients
  3. Texas $79,357 10% · 18 recipients
  4. Florida $64,282 8% · 34 recipients
  5. Oregon $60,979 8% · 7 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

7,960 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record